Next Article in Journal
Study of apoptosis in normal skin tissues
Previous Article in Journal
Importance of prostate volume for detection of prostate cancer by first sextant biopsy in high-risk patients
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Medicina
Volume 43
Issue 4
10.3390/medicina43040043
medicina-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences (LUHS), and Vilnius University.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

QTc-prolonging drugs and the risk of sudden death

by
Dagmara Reingardienė
1,* and
Jolita Vilčinskaitė
2
1
Department of Intensive Therapy, Kaunas University of Medicine
2
Clinic of Intensive Therapy, Kaunas University of Medicine Hospital, Lithuania
*
Author to whom correspondence should be addressed.
Medicina 2007, 43(4), 347; https://doi.org/10.3390/medicina43040043
Submission received: 26 May 2006 / Accepted: 16 March 2007 / Published: 21 March 2007
Versions Notes

Abstract

Various drugs can be associated with QT prolongation. A prolonged QT interval leads to an increased risk for the development of ventricular tachyarrhythmias, particularly polymorphic ventricular tachycardia (torsades de pointes). Polymorphic arrhythmia may rapidly develop into ventricular fibrillation and cause sudden death. Torsades de pointes is classically associated with early depolarization. This review article discusses the mechanisms of QTc prolongation and triggering factors for proarrhythmia, drugs that prolong QT interval (class III antiarrhythmic agents, antimicrobial agents – fluoroquinolone and macrolide antibiotics, antipsychotic and antidepressant drugs, agents used in general anesthesia, antimycotics, and several other drugs), nonpharmacological and pharmacological risk factors for arrhythmias (due to pharmacokineticpharmacodynamic interactions), the treatment and recommendations to prevent arrhythmia related to QT prolongation.
Keywords: acquired long QT syndrome; drug-related QTc prolongation; torsades de pointes, sudden death acquired long QT syndrome; drug-related QTc prolongation; torsades de pointes, sudden death

Share and Cite

MDPI and ACS Style

Reingardienė, D.; Vilčinskaitė, J. QTc-prolonging drugs and the risk of sudden death. Medicina 2007, 43, 347. https://doi.org/10.3390/medicina43040043

AMA Style

Reingardienė D, Vilčinskaitė J. QTc-prolonging drugs and the risk of sudden death. Medicina. 2007; 43(4):347. https://doi.org/10.3390/medicina43040043

Chicago/Turabian Style

Reingardienė, Dagmara, and Jolita Vilčinskaitė. 2007. "QTc-prolonging drugs and the risk of sudden death" Medicina 43, no. 4: 347. https://doi.org/10.3390/medicina43040043

APA Style

Reingardienė, D., & Vilčinskaitė, J. (2007). QTc-prolonging drugs and the risk of sudden death. Medicina, 43(4), 347. https://doi.org/10.3390/medicina43040043

Article Metrics

Back to TopTop